课题基金 / 基金详情

Centre for Blood Transplant and Cell Therapy

Centre for Blood Transplant and Cell Therapy
血液移植和细胞治疗中心
批准号:
nhmrc : GNT1135107
负责人:
A/Pr David Curtis
金额:
$250.0万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Centres of Research Excellence
财政年份:
2017
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2017-01-01 至 --

项目摘要

项目成果

A/Pr David Curtis的其他基金

相似基金

相关文献

中文摘要
翻译
澳大利亚每年有超过10,000人被诊断患有血癌,占癌症死亡人数的11%。干细胞移植仍然是这些疾病的治愈性疗法,但受到癌症复发和称为移植物抗宿主病(GVHD)的免疫介导过程的限制,这导致高达50%的患者死亡。该CRE将整合来自澳大利亚和美国的中心,以协调移植和细胞治疗的新疗法,以改善血癌的结果。
英文摘要
Over 10,000 persons per year in Australia are diagnosed with a blood cancer, accounting for 11% of cancer deaths. Stem cell transplantation remains curative therapy for these diseases but is limited by cancer relapse and an immune-mediated process known as graft-versus-host disease (GVHD) which account for death of up to 50% of patients. This CRE will integrate centres from Australia and the USA to coordinate new treatments in transplant and cell therapy to improve blood cancer outcomes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Curing blood cancers: rapid translation from target to drug to clinic
  • 批准号:
    nhmrc : 1139466
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $47.83万
  • 财政年份:
    2018
  • 负责人:
    A/Pr David Curtis
  • 依托单位:
Curing blood cancers: rapid translation from target to drug to clinic
  • 批准号:
    nhmrc : GNT1139466
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $64.02万
  • 财政年份:
    2018
  • 负责人:
    A/Pr David Curtis
  • 依托单位:
Centre for Blood Transplant and Cell Therapy
  • 批准号:
    nhmrc : 1135107
  • 项目类别:
    Centres of Research Excellence
  • 资助金额:
    $168.96万
  • 财政年份:
    2017
  • 负责人:
    A/Pr David Curtis
  • 依托单位:
Bone marrow Endothelial Stem Cells have the capacity to form both the endothelial and haemopoietic hierarchies
  • 批准号:
    nhmrc : GNT1084990
  • 项目类别:
    Project Grants
  • 资助金额:
    $139.41万
  • 财政年份:
    2015
  • 负责人:
    A/Pr David Curtis
  • 依托单位:
海外基金